News & Research

Find all the latest research, news and updates on Alzheimer’s disease blood-based biomarkers. Stay up to date with the latest educational materials from the BBM Workgroup.

Featured Stories

The Global CEO Initiative on Alzheimer’s Disease Publishes the First Performance Recommendations for Blood-Based Biomarker Tests by Experts in the Field

BBM Workgroup Activities & Educational Content:

News and Research
CEOi Launches Three Part Podcast Series, “A Breakthrough in Alzheimer’s Diagnostics: Integrating Blood Tests into Clinical Practice” in partnership with Pri-Med
CEOi submits letter to CMS in response to their proposed reimbursement for brain health biomarkers
Plain Language Summary of “Acceptable performance of blood biomarker tests of amyloid pathology — recommendations from the Global CEO Initiative on Alzheimer’s Disease”
Advancing Patient Care: Clinician Awareness, Attitudes, and Interest in Blood Tests forAlzheimer’s Disease
Acceptable performance of blood biomarker tests of amyloid pathology — recommendations from the Global CEO Initiative on Alzheimer’s Disease
The Global CEO Initiative on Alzheimer’s Disease Comment on the World Health Organization’s Preferred Product Characteristics for Blood Tests for Alzheimer’s Disease
The Global CEO Initiative on Alzheimer’s Disease Announces Expansion of its Blood-Based Biomarker Workgroup in 2024
CEOi Blood-Based Biomarker Symposium at AAGP 2024